Overview
The EGFR Mutation Test is an advanced genetic test used to detect changes (mutations) in the EGFR gene — a gene that plays an important role in cell growth and division. Mutations in this gene can cause cells to grow uncontrollably, leading to certain types of cancers, especially non-small cell lung cancer (NSCLC).
This test helps doctors understand whether a patient’s cancer is being driven by a specific EGFR mutation. If mutations are found, patients may respond extremely well to targeted therapy drugs, which can shrink tumors and slow cancer growth more effectively than traditional chemotherapy. Because of this, the EGFR Mutation Test has become a key component of personalized cancer treatment.
This article explains the test in simple language so that patients, families, students, and healthcare readers can understand every important detail.
What is the EGFR Mutation Test?
The EGFR Mutation Test checks for specific genetic changes in the Epidermal Growth Factor Receptor (EGFR) gene. This test is usually performed on:
- Tumor tissue collected during biopsy
- Blood samples (liquid biopsy), which detect circulating tumor DNA
- Pleural fluid or other body fluids (in selected cases)
EGFR mutations are especially common in:
- Non-smokers
- Asian populations
- Women
- People with adenocarcinoma-type lung cancer
Finding an EGFR mutation allows doctors to choose the most effective targeted medicine for treatment.
Where is EGFR Produced in the Body?
EGFR is a protein located on the surface of many cells, especially those found in:
- Skin
- Lungs
- Digestive tract
- Other epithelial tissues
This protein plays a major role in:
- Cell growth
- Cell repair
- Cell survival
The EGFR gene, located on chromosome 7, provides the instructions for making this protein.
Important point:
Mutations in the EGFR gene do not occur in healthy cells.
They occur within tumor cells, due to genetic damage or alteration in the cancer.
Why is the EGFR Mutation Test Important?
The test has several major uses in modern cancer care:
1. Detects Cancer-Driving Mutations
EGFR mutations allow cancer cells to grow, divide, and spread quickly. Finding these mutations helps identify the exact cause of tumor growth.
2. Helps Select the Best Targeted Therapy
Certain medicines, known as Tyrosine Kinase Inhibitors (TKIs), work specifically on EGFR-mutated tumors. These include:
- Erlotinib
- Gefitinib
- Afatinib
- Dacomitinib
- Osimertinib (effective even for resistance mutation T790M)
Patients with mutations usually respond dramatically better to these medicines.
3. Predicts Treatment Response
Some mutations respond very well to TKIs, while others may show partial or limited response.
4. Avoids Unnecessary Chemotherapy
If targeted therapy is effective, aggressive chemotherapy may be postponed or avoided.
5. Enables Personalized Cancer Treatment
The test helps tailor treatment specifically for each patient based on their genetic profile.
Common EGFR Mutations Detected by the Test
Some mutations are known to respond especially well to targeted therapy:
- Exon 19 deletion
- Exon 21 L858R mutation
- T790M mutation – often associated with resistance after initial treatment
- Exon 20 insertion – may require special targeted drugs
Each mutation carries a different treatment implication, making detection highly valuable.
Causes of Low/Negative EGFR Mutation Levels
A negative EGFR mutation result simply means no detectable mutation was found in the sample.
Reasons include:
1. The Tumor Does Not Have EGFR Mutations
Cancer may be caused by other genetic abnormalities.
2. Tumor Driven by Other Genes
Examples:
- KRAS
- ALK
- ROS1
- BRAF
- MET
These require different targeted therapies.
3. Poor Sample Quality
Sometimes the biopsy does not contain enough tumor cells for accurate testing.
4. Technical / Processing Errors
Rare but possible in low-quality or degraded samples.
Symptoms Associated With Negative EGFR Results
The negative result itself does not cause symptoms.
However, the underlying cancer may show:
- Long-lasting cough
- Chest discomfort or pain
- Breathlessness
- Fatigue
- Loss of appetite
- Weight loss
These symptoms depend on how far the cancer has progressed.
Causes of High/Positive EGFR Mutation Levels
A positive test means that an EGFR mutation is present in the tumor. This is usually caused by:
1. Genetic Alterations in Cancer Cells
Changes in the DNA of lung cancer cells lead to the mutation.
2. Environmental Factors
- Air pollution
- Tobacco smoke
- Exposure to chemicals
- Radiation exposure
3. Genetic Susceptibility
In rare cases, people may be more prone to acquiring such mutations.
Symptoms Associated With Positive EGFR Mutation
Again, the mutation itself has no symptoms.
But cancers driven by EGFR mutation may show:
- Chronic cough (sometimes with blood)
- Wheezing
- Shortness of breath
- Chest or rib pain
- Bone pain if the cancer spreads
- Headaches, seizures if it spreads to the brain
Symptoms depend on the cancer stage and organs involved.
Reference Ranges for EGFR Mutation Test
This test does not have a numerical range like blood tests.
Instead, it gives a qualitative result:
• Negative:
No EGFR mutation detected.
• Positive:
EGFR mutation detected. Examples:
- Exon 19 deletion
- Exon 21 L858R
- T790M
- Exon 20 insertion
Doctors interpret the significance based on mutation type and cancer stage.
Sample Type for the EGFR Mutation Test
Samples commonly used include:
1. Tumor Tissue Biopsy
Lung tissue is most commonly used.
2. Blood Sample (Liquid Biopsy)
Detects circulating tumor DNA (ctDNA).
Useful when biopsy is not possible or for monitoring resistance.
3. Body Fluids
In some cases, testing may be performed on:
- Pleural fluid
- Ascitic fluid
- Other fluids containing tumor cells
How the Test is Performed
- Sample is collected (biopsy tissue or blood).
- DNA is extracted from the tumor cells.
- Genetic sequencing methods (PCR, NGS) are used.
- Specific mutations are mapped and reported.
Test Preparation
- No fasting required.
- Avoid smoking before the test (if blood sample).
- Inform doctor about previous treatments (TKIs, chemotherapy).
- Provide prior biopsy reports for comparison.
- Ensure enough tissue sample is available during biopsy.
When to Consult a Doctor
Seek medical advice if:
- You are diagnosed with lung cancer and need mutation testing.
- Initial targeted therapy stops working.
- Symptoms worsen (breathlessness, chest pain).
- Cancer progresses despite ongoing treatment.
- You have a family history of lung cancer.
Immediate attention is needed if you develop:
- Severe breathing difficulty
- Coughing blood
- Sudden neurological symptoms (seizures, sudden weakness)
Important Word Explanations
- EGFR: Protein that helps cells grow and divide.
- Mutation: Change in DNA sequence.
- NSCLC: Non-small cell lung cancer.
- TKI (Tyrosine Kinase Inhibitor): Drug that blocks cancer growth signals.
- Liquid Biopsy: Blood test that detects tumor DNA.
- Exon: A gene segment where mutations may occur.
- Metastasis: Spread of cancer to other body parts.
~END~